Cytokinetics (CYTK) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Cytokinetics

    NASDAQ: CYTK · Real-Time Price · USD
    51.50
    -0.59 (-1.13%)
    At close: Sep 09, 2025, 3:59 PM
    50.18
    -2.56%
    After-hours: Sep 09, 2025, 07:10 PM EDT

    Cytokinetics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -8.94 -15.31 -10.58 -16.28
    PEG Ratio
    		 2.56 -0.59 -0.19 -0.39
    PS Ratio
    		 285.13 1.07K 43.51 49.76
    PB Ratio
    		 -38.91 -20.86 -38.14 14.37
    P/FCF Ratio
    		 -13.18 -19.38 -13.24 -18.31
    P/OCF Ratio
    		 -13.31 -19.45 -13.74 -24.59
    OCF/S Ratio
    		 -21.43 -55.02 -3.17 -2.02
    Debt / Equity Ratio
    		 -5.83 -1.96 -6.94 1.11
    Quick Ratio
    		 6.17 6.12 9.40 7.45
    Current Ratio
    		 6.17 6.12 9.40 7.45
    Asset Turnover
    		 0.01 0.01 0.09 0.08
    Interest Coverage
    		 -6.2 -8.6 -6.34 -6.35
    Return on Equity
    		 4.35 1.36 3.60 -0.88
    Return on Assets
    		 -0.42 -0.64 -0.38 -0.26
    Return on Invested Capital
    		 -0.43 -0.66 -0.34 -0.23
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 -17.37 -42.84 -1.55 -1.27
    Net Profit Margin
    		 -31.91 -69.89 -4.11 -3.06
    Pretax Profit Margin
    		 -31.91 -69.89 -4.11 -3.06
    Operating Profit Margin
    		 -29.03 -65.9 -3.43 -2.65
    FCF Margin
    		 -21.64 -55.21 -3.29 -2.72
    EBITDA Margin
    		 -26.71 -60.65 -3.48 -2.5

    Add to Watchlist